News | The Biotech Times

Featured Articles

Pharmaceuticals

Regulatory Science

GH Research publishes Phase 2a PPD data for inhaled GH001

All ten patients in GH Research's open-label trial achieved remission within two hours of a single inhaled dose of mebufotenin, the company reports.

All ten patients in GH Research's open-label trial achieved remission within two hours of a single inhaled dose of mebufotenin, the company reports.

The Biotech Times Editorial Team · 5 June 2026
Regulatory Science

Amplia launches Phase 2b narmafotinib trial in pancreatic cancer

Amplia Therapeutics is initiating a daily-dosing Phase 2b study of its FAK inhibitor narmafotinib in advanced pancreatic cancer, with enrolment due by Q4 2026.

Amplia Therapeutics is initiating a daily-dosing Phase 2b study of its FAK inhibitor narmafotinib in advanced pancreatic cancer, with enrolment due by Q4 2026.

The Biotech Times Editorial Team · 2 June 2026
Diagnostics

Jelly Lean gummy supplement rides viral "Pink Gelatin Trick" wave

A ClickBank-distributed ACV and BHB gummy has surged in searches after a viral pre-meal satiety trend, but counterfeit listings cloud the market.

A ClickBank-distributed ACV and BHB gummy has surged in searches after a viral pre-meal satiety trend, but counterfeit listings cloud the market.

The Biotech Times Editorial Team · 6 May 2026
Digital Health

KFSH Named Saudi Arabia's Most Valuable Healthcare Brand

King Faisal Specialist Hospital and Research Centre (KFSH) has been named Saudi Arabia & the Middle East’s Most Valuable Healthcare Brand for the fourth consecutive year

King Faisal Specialist Hospital and Research Centre (KFSH) has been named Saudi Arabia and the Middle East’s Most Valuable Healthcare Brand for the fourth consecutive year, with its brand value surpassing USD 1.7 billion (SAR 6.3 billion), according to Brand Finance’s 2026 ran

The Biotech Times Editorial Team · 30 April 2026
AgriTech

MW Does a test

Headline subtitle

test schedule

Mark Walker · 27 April 2026

Born to Disrupt, Nicholas Bingham on Building a Biotech and Data Future for the GCC

The Biotech Times Editorial Team · 27 October 2025

Cell & Gene Therapy

The Royal Marsden Pioneers CAR-T Therapy for Multiple Myeloma in the UK

During Blood Cancer Awareness Month, The Royal Marsden becomes the first UK centre to treat multiple myeloma patients with CAR-T therapy outside clinical trials

During Blood Cancer Awareness Month, The Royal Marsden becomes the first UK centre to treat multiple myeloma patients with CAR-T therapy outside clinical trials, offering renewed hope and

The Biotech Times Editorial Team · 24 October 2025

Medical Devices

Saudi Arabia Reframes Healthcare as Strategic Investment for Innovation

Saudi Arabia’s KFSHRC leads with AI, robotics, and precision medicine, supporting Vision 2030 and global collaboration in sustainable healthcare systems.

H.E. Dr. Majid Alfayyadh urges viewing healthcare as a driver of security, prosperity, and innovation.

The Biotech Times Editorial Team · 23 October 2025

Medical Devices

Hub71 + Life Sciences: Abu Dhabi’s Next Chapter in Healthcare Innovation

Discover how Hub71’s new Life Sciences vertical is transforming Abu Dhabi into a global hub for biotechnology, digital health, and medical innovation — with startups like Bio Sapien and E

The Biotech Times Editorial Team · 23 October 2025

Medical Devices

Prosper AI Raises $5M to Automate Healthcare’s Administrative Burden

Prosper AI secures $5M seed funding to scale its healthcare-specialized voice AI agents, automating patient and payer calls, reducing costs, and improving efficiency for hospitals, billin

The Biotech Times Editorial Team · 15 October 2025

Medical Devices

Ant Group Expands AI Healthcare & Finance Services in China

Ant Group’s AQ app launches AI updates to improve healthcare access nationwide, while Ant Fortune opens AI tools for financial institutions, bridging urban-rural gaps and empowering docto

The Biotech Times Editorial Team · 3 October 2025

UK Tech Funding Hits $7.8B in H1 2025, Ranks 2nd Globally

Tracxn reports $7.8B in UK tech funding for H1 2025, driven by strong late-stage deals and sectoral growth in FinTech, Media, and Enterprise.

The Biotech Times Editorial Team · 3 July 2025

Digital Health

e& Enterprise and LifeBot Partner to Deliver Advanced Telemedicine Across UAE

e& enterprise teams up with LifeBot to bring ICU-grade telemedicine to remote areas in the UAE, enhancing healthcare access with real-time diagnostics and sustainable, high-performanc

The Biotech Times Editorial Team · 8 May 2025

Medical Devices

MBZUAI Leads AI Innovations to Improve Maternal and Newborn Health

Mohamed bin

The Biotech Times Editorial Team · 25 April 2025

Medical Devices

e& Enterprise Partners with RAIN Technology to Revolutionize OR Workflows in MEA

e& Enterprise teams up with RAIN Technology to launch Orva, an AI-powered voice assistant, transforming operating room workflows and

The Biotech Times Editorial Team · 8 April 2025

Medical Devices

AI Revolutionizes Healthcare Delivery: Insights from Arab Health 2025

The integration of Artificial Intelligence (AI) into healthcare is redefining patient care and advancing medical outcomes, as demonstrated by insights from the inaugural Digital Health &a

The Biotech Times Editorial Team · 28 January 2025

Medical Devices

Nelly Announces EUR 50 Million Series B Funding Round to Revolutionize Financial Operations in Healthcare

Berlin-based health and fintech company Nelly has raised €50 million. With this Series B financing, the company aims to accelerate the digitalization of the European healthcare sector.

The Biotech Times Editorial Team · 15 January 2025

Subscribe to

Featured Articles

During Blood Cancer Awareness Month, The Royal Marsden becomes the first UK centre to treat multiple myeloma patients with CAR-T therapy outside clinical trials, offering renewed hope and

H.E. Dr. Majid Alfayyadh urges viewing healthcare as a driver of security, prosperity, and innovation.

Discover how Hub71’s new Life Sciences vertical is transforming Abu Dhabi into a global hub for biotechnology, digital health, and medical innovation — with startups like Bio Sapien and E

Prosper AI secures $5M seed funding to scale its healthcare-specialized voice AI agents, automating patient and payer calls, reducing costs, and improving efficiency for hospitals, billin

Ant Group’s AQ app launches AI updates to improve healthcare access nationwide, while Ant Fortune opens AI tools for financial institutions, bridging urban-rural gaps and empowering docto

Tracxn reports $7.8B in UK tech funding for H1 2025, driven by strong late-stage deals and sectoral growth in FinTech, Media, and Enterprise.

e& enterprise teams up with LifeBot to bring ICU-grade telemedicine to remote areas in the UAE, enhancing healthcare access with real-time diagnostics and sustainable, high-performanc

Mohamed bin

e& Enterprise teams up with RAIN Technology to launch Orva, an AI-powered voice assistant, transforming operating room workflows and

The integration of Artificial Intelligence (AI) into healthcare is redefining patient care and advancing medical outcomes, as demonstrated by insights from the inaugural Digital Health &a

Berlin-based health and fintech company Nelly has raised €50 million. With this Series B financing, the company aims to accelerate the digitalization of the European healthcare sector.

Subscribe to The Biotech Times